KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Common Equity (2016 - 2025)

Astrana Health (ASTH) has disclosed Common Equity for 15 consecutive years, with $779.3 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 8.73% to $779.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $779.3 million through Dec 2025, up 8.73% year-over-year, with the annual reading at $779.3 million for FY2025, 8.73% up from the prior year.
  • Common Equity hit $779.3 million in Q4 2025 for Astrana Health, roughly flat from $775.5 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $779.3 million in Q4 2025 to a low of $347.0 million in Q1 2021.
  • Historically, Common Equity has averaged $590.8 million across 5 years, with a median of $583.7 million in 2023.
  • Biggest five-year swings in Common Equity: skyrocketed 92.15% in 2021 and later grew 8.73% in 2025.
  • Year by year, Common Equity stood at $454.1 million in 2021, then rose by 19.86% to $544.3 million in 2022, then grew by 13.29% to $616.7 million in 2023, then rose by 16.23% to $716.7 million in 2024, then rose by 8.73% to $779.3 million in 2025.
  • Business Quant data shows Common Equity for ASTH at $779.3 million in Q4 2025, $775.5 million in Q3 2025, and $771.5 million in Q2 2025.